Re: CABG
>The proposed "fixes" to this problem in response to the Australian study did not sound very robust to me.<
OK—glad we agree on that! The upbeat tone of CABG’s PR had me wondering if I had missed something.
>Still, the device might fly if they can keep the [occlusion] rate down, since occlusion is ultimately a common outcome for traditional bypass anyways.<
Merely reducing—rather than eliminating—the CABG occlusion rate does not make for an especially sexy story line relative to the company’s original aspirations. It's not unlike what I perceive is the changed story at GENR, where the early goal of improving vision in AMD has yielded to the less sexy goal of merely stabilizing vision.
Market Data 
Markets 
AI
